MedTrace Logo

PET Guided Bone Marrow Biopsy vs Trephine Bone Marrow Biopsy

NCT05251168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-02-23

No results posted yet for this study

Summary

Newly diagnosed lymphoma patients were recruited for FDG PET/CT and PET/CT guided bone marrow biopsy. All the patients also underwent routine bone marrow sampling from the posterior superior iliac spine.

Conditions

Interventions

PROCEDURE

PET Guided Bone Marrow Biopsy

The results of PET/CT images were discussed with the referring physician. PET/CT targeted metabolic marrow biopsy was planned two hours after the whole body diagnostic imaging or on a subsequent day one hour after injecting 2-3 mCi of FDG to minimize the radiation exposure burden to the interventionist. Society of Interventional Consensus guidelines was followed for image-guided biopsy. The bone marrow biopsy was done under the PET/CT guidance using the same PET/CT scanner with the help of an automated robotic arm (ARA) workstation

PROCEDURE

Trephine Bone Marrow Biopsy

All the participants underwent trephine bone marrow biopsies from the bilateral posterior superior iliac spine before treatment planning.

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-12-31
Completion
2019-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251168 on ClinicalTrials.gov